U.S. Consumer Services Stock News

What Zurn Elkay Water Solutions’ Recent Performance Signals for Investors Zurn Elkay Water Solutions (ZWS) has drawn fresh attention after a period of mixed short term returns, with the stock showing a 1 day decline, a small weekly pullback, yet gains over the past month and past 3 months. At a last close of US$49.93, the company sits on a 1 year total return of 44.56%. Longer horizons show very large gains over 3 and 5 years, alongside annual revenue of US$1.70b and net income of...

In February 2026, iRhythm Holdings reported Q4 2025 results showing sales of US$208.89 million and a return to quarterly profitability, while full-year 2025 revenue reached US$747.14 million with a reduced annual net loss. The company also issued 2026 revenue guidance of US$870 million to US$880 million and highlighted expansion plans, AI-enabled product development, and international growth initiatives as it works to improve efficiency and broaden its cardiac monitoring platform. We’ll now...

Clear Secure (NYSE:YOU) announced a collaboration with Mount Sinai Health System to roll out its CLEAR1 digital identity platform across the New York City based healthcare network. The agreement focuses on improving identity verification and check in for both patients and employees within one of the region's largest academic medical systems. Clear Secure, trading at $32.73, is best known for its airport security lanes, but this move signals a push into healthcare identity services. The...

Genuine Parts plans to separate into two independent, tax free companies by Q1 2027. The split will create a dedicated Global Automotive business and a separate Global Industrial business. The company expects the separation to sharpen business focus and reshape its long term direction. For NYSE:GPC shareholders, this planned breakup comes after a challenging stretch for the stock. Shares are at $116.16, with a 21.1% decline over the past week and a 15.6% decline over the past month. Over 3...

If you are wondering whether Collegium Pharmaceutical at around US$44.85 is good value or looking fully priced, the key is understanding how its current share price stacks up against a few different valuation checks. The stock has had a mixed run recently, with a 2.1% decline over the last 7 days and a 1.4% decline over the last 30 days, even though the 1 year return sits at 53.6% and the 3 year return at 67.4%. Recent attention on Collegium has focused on its position within the US...

In the past few days, law firm Kirby McInerney LLP announced it is investigating Alvotech and certain executives for potential federal securities law violations after the FDA issued a complete response letter citing a failed facility inspection for its AVT05 biologics license application. This combination of regulatory setback and investor scrutiny raises fresh questions about Alvotech’s quality controls, regulatory risk management, and disclosure practices around its biosimilar...

Fiverr International (NYSE:FVRR) has restructured its executive team, appointing a new Chief Financial Officer and introducing a Chief Business Officer role. The leadership changes are aimed at addressing rising operational complexity and supporting the company’s long term goals. These moves come as Fiverr faces stronger competitive pressures and continues its push toward serving higher value clients. Fiverr operates a global online marketplace that connects freelancers with businesses...

Griffon (GFF) is back in focus after fiscal Q1 results topped expectations, alongside a new AMES North America and Venanpri Tools joint venture, continued share buybacks, and the company’s 58th consecutive quarterly dividend. See our latest analysis for Griffon. Despite a 2.3% one day share price decline and a 7.5% 7 day share price pullback, Griffon’s 30 day and 90 day share price returns of 3.7% and 14.9% respectively, together with a 1 year total shareholder return of 22.4% and a 3 year...

MFA Financial (MFA) is on investor watch after posting annual revenue of US$325.4 million and net income of US$135.7 million, with recent returns mixed over the day, week, month and past 3 months. See our latest analysis for MFA Financial. At a share price of US$9.90, MFA Financial has seen short term share price softness alongside a positive 3 month share price return and a stronger 1 year total shareholder return of 11.27%. This suggests that recent price swings are occurring within a more...

Spectrum Brands Holdings (SPB) has drawn fresh attention after recent trading left the stock with a one-month return of 22% and a gain of 34.1% over the past three months, sharpening interest in its consumer brands portfolio. See our latest analysis for Spectrum Brands Holdings. That recent run sits on top of a 31.43% year to date share price return as the stock trades at US$78.91. The 1 year total shareholder return of 3.46% and 3 year total shareholder return of 33.70% suggest momentum has...

NasdaqGS:NDAQ has launched the Nasdaq Private Capital Indexes, a new suite of benchmarks for private markets. The indexes aim to provide greater transparency and standardized performance measurement for private capital investments. The launch is designed to serve institutional investors, consultants, and other market participants that use private market data. NasdaqGS:NDAQ operates as a global technology and market infrastructure provider, with data, analytics, and index services sitting...

The U.S. FDA is now reviewing Moderna’s mRNA flu vaccine application after previously issuing a Refusal to File tied to the study’s choice of comparator. This reversal reopens the regulatory path for Moderna’s mRNA flu program, which is part of the company’s broader respiratory vaccine portfolio. The shift follows public criticism of the initial decision and comes at a time when mRNA platforms remain central to Moderna’s long term product plans. For investors watching NasdaqGS:MRNA, this...

Advanced Energy Industries (NasdaqGS:AEIS) is actively pursuing acquisitions to expand its presence, with recent deals focused on industrial and medical technology. Management has highlighted a busy acquisition pipeline and points to recent integration of new technology as evidence that its inorganic growth push is gaining traction. The company is signaling that further deals in industrial and medical markets are a priority, with the goal of reshaping its portfolio around higher value...

Cognizant Technology Solutions (CTSH) has drawn investor attention after a period of weak share performance, with returns negative over the past month, past 3 months, year to date, and past year. See our latest analysis for Cognizant Technology Solutions. The recent 6% one day share price decline, extending to a 27.38% 30 day share price return and a 26.41% 1 year total shareholder return, points to fading momentum as investors reassess growth prospects and risk. If Cognizant’s pullback has...

If you are wondering whether Atmos Energy is attractively priced at its current level, this article will walk through what the market price might be saying about the stock. The shares last closed at US$181.72, with returns of 1.4% over 7 days, 9.9% over 30 days, 7.3% year to date, 24.4% over 1 year, 70.3% over 3 years and 140.1% over 5 years. Recent investor attention has focused on Atmos Energy as a regulated utility with a long standing role in US gas distribution. This has kept it in many...

Zacks recently upgraded McEwen to a Rank #2 (Buy), reflecting higher earnings estimates and signaling that analysts view its underlying operations more favorably than before. This shift in analyst sentiment places McEwen among the stronger names in the Zacks universe for earnings revisions, highlighting how changing expectations can influence market attention. We’ll now examine how this Zacks Rank upgrade, driven by improved earnings estimates, may influence McEwen’s existing investment...

If you are wondering whether Skyworks Solutions is attractively priced or just a value trap, you are in the right place for a clear, valuation focused look at the stock. The share price last closed at US$59.78, with returns of 1.4% over the past 30 days, a 7.2% decline year to date, and a 6.2% decline over the last year that longer term holders will be very aware of. Recent coverage of Skyworks has centered on its role as a key semiconductor supplier and on how demand trends across...

If you are wondering whether OFG Bancorp at around US$41.39 is still good value or already pricing in a lot of optimism, you are asking the right question. The stock has had mixed recent returns, with a 1.2% decline over the last 7 days, an 11.4% gain over 30 days, 0.9% year to date, 2.4% over 1 year, 50.3% over 3 years and 134.3% over 5 years, which can change how investors think about both upside and risk. Recent news around OFG Bancorp has focused on its position as a US regional bank and...

If you are wondering whether Coty’s share price now reflects a fair deal or a value trap, you are not alone. This article focuses squarely on what the current valuation is really telling you. The stock recently closed at US$2.59, with returns of 3.2% over 7 days, a 22.9% decline over 30 days, a 16.7% decline year to date, and a 56.8% decline over 1 year, while the 3 year and 5 year returns stand at 76.9% and 67.9% declines respectively. Recent news around Coty has focused on its brand...

Day One Biopharmaceuticals (DAWN) is back in focus after the company set February 24, 2026 as the date for its Q4 2025 earnings release and accompanying conference call. See our latest analysis for Day One Biopharmaceuticals. At a share price of $11.70, Day One Biopharmaceuticals has a 90 day share price return of 24.07% and a year to date share price return of 32.20%. The 1 year total shareholder return is 3.94% lower, which indicates that more recent momentum has picked up ahead of the...

Ategrity Specialty Insurance Company Holdings (ASIC) has drawn fresh attention after a sharp recent move in its share price, with the stock up 6.1% over the past day and 32.7% in the past week. See our latest analysis for Ategrity Specialty Insurance Company Holdings. The recent surge in Ategrity Specialty Insurance Company Holdings’ share price, including a 32.7% 7 day share price return and a 23.97% 90 day share price return, suggests short term momentum is building while year to date...

Berkshire Hathaway disclosed in the fourth quarter that it acquired a little more than five million shares of The New York Times Company, while separately New York Times Advertising and Magnite previously announced an expanded collaboration making Magnite's DV+ the preferred platform for private marketplace deals for the publisher’s mobile in‑app ad supply. The combination of a high‑profile shareholder like Berkshire Hathaway and a deeper in‑app advertising partnership highlights how New...

Hims & Hers Health (NYSE:HIMS) launched a compounded GLP-1 weight-loss medication and withdrew it shortly after following FDA scrutiny. Novo Nordisk has filed a patent infringement lawsuit against Hims & Hers related to compounded GLP-1 therapies. The company announced its largest-ever acquisition, Eucalyptus, as it pursues global expansion beyond weight-loss offerings. Hims & Hers Health focuses on telehealth-driven, direct-to-consumer treatments across areas like hair loss, mental health,...

Scotts Miracle-Gro (SMG) has been drawing fresh attention after a recent stretch of mixed share performance, including a 1.2% one-day decline contrasted with gains over the past month and the past three months. See our latest analysis for Scotts Miracle-Gro. That 1.2% one day share price decline comes after a stronger stretch, with the 30 day share price return of 10.2% and 90 day share price return of 24.7% pointing to building momentum despite a mixed longer term picture, including a 1 year...